Elhadj Djeriou Selected Research

ferroquine

8/2017	Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria.
9/2016	A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study.
12/2015	Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elhadj Djeriou Research Topics

Disease

4	Malaria 01/2020 - 12/2015
2	Infections 01/2020 - 09/2016
2	Falciparum Malaria (Plasmodium falciparum Malaria) 08/2017 - 12/2015
1	Parasitic Diseases (Parasitic Disease) 01/2020

Drug/Important Bio-Agent (IBA)

3	ferroquineIBA 08/2017 - 12/2015
2	artemisinin (artemisinine)IBA 08/2017 - 12/2015
2	ArtesunateIBA 08/2017 - 12/2015
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2020
1	VaccinesIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	EnzymesIBA 01/2020
1	Amodiaquine (Camoquin)FDA Link 08/2017
1	1,12- bis(4- methyl- 5- (2- hydroxyethyl)thiazol- 3- ium- 3- yl)dodecaneIBA 01/2017
1	Choline (Choline Chloride)IBA 01/2017
1	Antimalarials (Antimalarial Agents)IBA 09/2016
1	Drug CombinationsIBA 12/2015
1	antineoplaston A10 (A 10)IBA 12/2015

Therapy/Procedure

3	Therapeutics 08/2017 - 12/2015